Patent · US Active

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

US10695425B2 · kind B2 · utility

0Cited by
12References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 20, 2018
Grant dateJun 30, 2020
Priority date
Expiry dateJun 14, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating and/or limiting development of diabetes in a subject with amyotrophic lateral sclerosis (ALS) by inhibiting IgG-mediated activation of voltage-gated calcium channels (VGCCs) in cells of the subject, by one or more of removing IgG from blood of the subject, blocking IgG from activating VGCCs in the subject; or blocking VGCCs in the subject are described, as are methods for identifying ALS patients at risk of developing diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.